
Annual report 2025
added 02-12-2026
AVITA Medical Cash Flow 2011-2026 | RCEL
Annual Cash Flow AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-31.2 M | -48.9 M | -38 M | -19.1 M | -5.5 M | -22.7 M | -19.2 M | -13 M | - | - | - | - | - | - | - |
Depreciation & Amortization |
2.35 M | 1.13 M | 632 K | 568 K | 330 K | 465 K | 269 K | 110 K | - | - | - | - | - | - | - |
Accounts Receivables |
9.09 M | 11.8 M | 7.66 M | 3.52 M | 3.12 M | 2.08 M | - | - | - | - | - | - | - | - | - |
Total Inventories |
6.93 M | 7.27 M | 5.6 M | 2.12 M | 2.13 M | 1.12 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow AVITA Medical
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -10.3 M | - | - | - | -20.9 M | - | - | - | -9.07 M | - | -15.7 M | -12.9 M | -9.37 M | - | -13.1 M | -12.5 M | -8.54 M | - | -7.71 M | -13.4 M | -7.71 M | - | -4.88 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
421 K | 521 K | - | 288 K | 187 K | 203 K | - | 156 K | 137 K | 135 K | - | 130 K | 129 K | 163 K | - | 517 K | 343 K | 167 K | 135 K | 211 K | 373 K | 211 K | 88 K | 66 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
9.01 M | 12 M | 11.8 M | 10.3 M | 8.72 M | 7.08 M | 7.66 M | 5.88 M | 5.75 M | 4.5 M | 3.52 M | 3.55 M | 3.88 M | 3.48 M | 3.12 M | 3.12 M | 3.47 M | 3.47 M | 1.94 M | 2.36 M | 2.08 M | 2.08 M | - | - | 1.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
7.24 M | 8.4 M | 7.27 M | 6.23 M | 6.71 M | 7.17 M | 5.6 M | 4.38 M | 3.06 M | 2.81 M | 2.12 M | 1.96 M | 2.02 M | 1.8 M | 2.13 M | 1.89 M | 1.65 M | 1.65 M | 2.29 M | 1.66 M | 1.12 M | 1.12 M | - | - | 742 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Cash Flow Statement is one of the three key financial reports of the company AVITA Medical, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.
Main Sections of the Cash Flow Statement- Operating Activities
This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash. - Investing Activities
Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign. - Financing Activities
Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.
The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.
Cash flow statements of other stocks in the Medical devices sector
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
|
ClearPoint Neuro
CLPT
|
$ 11.1 | -0.72 % | $ 314 M | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | ||
|
Electromed
ELMD
|
$ 25.81 | 0.98 % | $ 218 M | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | ||
|
Helius Medical Technologies
HSDT
|
$ 2.16 | - | $ 1.31 M | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.45 | 3.29 % | $ 129 M | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.61 | -2.42 % | $ 38 M | ||
|
Delcath Systems
DCTH
|
$ 11.53 | 4.63 % | $ 413 M | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | ||
|
LivaNova PLC
LIVN
|
$ 57.59 | -2.51 % | $ 3.14 B | ||
|
LENSAR
LNSR
|
$ 5.48 | -1.44 % | $ 65.5 M | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | ||
|
Insulet Corporation
PODD
|
$ 167.53 | -2.25 % | $ 11.8 B | ||
|
Inspire Medical Systems
INSP
|
$ 48.25 | -12.02 % | $ 1.42 B | ||
|
IRIDEX Corporation
IRIX
|
$ 1.05 | -3.23 % | $ 17.8 M | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | ||
|
Sintx Technologies
SINT
|
$ 2.42 | - | $ 6.71 M | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 17.04 | 7.98 % | $ 400 M | ||
|
Butterfly Network
BFLY
|
$ 4.82 | -0.52 % | $ 1.02 B | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | ||
|
TransMedics Group
TMDX
|
$ 94.93 | -2.21 % | $ 3.23 B | ||
|
Tandem Diabetes Care
TNDM
|
$ 19.42 | -2.26 % | $ 1.32 B | ||
|
Globus Medical
GMED
|
$ 90.03 | -0.63 % | $ 12.2 B | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | ||
|
CONMED Corporation
CNMD
|
$ 36.64 | 2.12 % | $ 1.14 B | ||
|
Stryker Corporation
SYK
|
$ 295.25 | 1.5 % | $ 113 B | ||
|
Integer Holdings Corporation
ITGR
|
$ 85.85 | 2.26 % | $ 2.98 B | ||
|
Edwards Lifesciences Corporation
EW
|
$ 82.91 | -0.5 % | $ 48.5 B | ||
|
Pulmonx Corporation
LUNG
|
$ 1.27 | -4.51 % | $ 51.7 M | ||
|
MiMedx Group
MDXG
|
$ 3.64 | 0.83 % | $ 538 M | ||
|
Myomo
MYO
|
$ 0.88 | 1.69 % | $ 36.8 M |